The signaling molecular mechanisms in zebrafish response to electricity
are unknown, so here we asked if changes to dopaminergic signaling
pathways can affect their electrically-evoked locomotion. To answer this
question, the effects of multiple selective and non-selective dopamine
compounds on the electric response of zebrafish larvae is investigated.
A microfluidic device with enhanced control of experimentation with
multiple larvae is used, which features a novel design to immobilize
four zebrafish larvae in parallel and expose them to electric current
that induces tail locomotion. In 6 days post-fertilization zebrafish
larvae, the electric induced locomotor response is quantified in terms
of the tail movement duration and beating frequency to discern the
effect of non-lethal concentrations of dopaminergic agonists
(apomorphine, SKF-81297, and quinpirole), and antagonists (butaclamol,
SCH-23390, and haloperidol). All dopamine antagonists decrease locomotor
activity, while dopamine agonists do not induce similar behaviours in
larvae. The D2- like selective dopamine agonist quinpirole enhances
movement. However, exposure to non-selective and D1-selective dopamine
agonists apomorphine and SKF-81297 cause no significant change in the
electric response. Exposing larvae that were pre-treated with butaclamol
and haloperidol to apomorphine and quinpirole, respectively, restores
electric locomotion. The results demonstrate a correlation between
electric response and the dopamine signalling pathway. We propose that
the electrofluidic assay has profound application potential as a
chemical screening method when investigating biological pathways,
behaviors, and brain disorders.